Dow Down 0.18% Nasdaq Down 0.33%

ImmunoGen, Inc. (IMGN)

-NasdaqGS
9.38 Oct 29, 4:00PM EDT
Prev Close:9.38
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:15.27
Beta:2.08
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:7.70 - 17.80
Volume:0
Avg Vol (3m):1,063,740
Market Cap:805.05M
P/E (ttm):N/A
EPS (ttm):-0.96
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMGN

Comparison

Symbol% ChgMkt Cap
IMGN 0.00%805.05M
PFE186.99B
RHHBY249.58B
SGEN4.35B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):14.41
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.73
Quarterly EPS Est (Dec-14) :-0.18
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback